{"id":"cromolyn-sodium","rwe":[],"tags":[],"safety":{"boxedWarnings":[],"safetySignals":[{"date":"","signal":"TREATMENT FAILURE","source":"FDA FAERS","actionTaken":"1004 reports"},{"date":"","signal":"DRUG INEFFECTIVE","source":"FDA FAERS","actionTaken":"314 reports"},{"date":"","signal":"FATIGUE","source":"FDA FAERS","actionTaken":"207 reports"},{"date":"","signal":"NAUSEA","source":"FDA FAERS","actionTaken":"184 reports"},{"date":"","signal":"HEADACHE","source":"FDA FAERS","actionTaken":"179 reports"},{"date":"","signal":"DIARRHOEA","source":"FDA FAERS","actionTaken":"155 reports"},{"date":"","signal":"DYSPNOEA","source":"FDA FAERS","actionTaken":"149 reports"},{"date":"","signal":"OFF LABEL USE","source":"FDA FAERS","actionTaken":"142 reports"},{"date":"","signal":"URTICARIA","source":"FDA FAERS","actionTaken":"141 reports"},{"date":"","signal":"HYPERSENSITIVITY","source":"FDA FAERS","actionTaken":"132 reports"}],"drugInteractions":[{"drug":"Isoproterenol","action":"Avoid","effect":"Increased incidence of major malformations when used together in pregnant mice."}],"commonSideEffects":[{"effect":"Transient ocular stinging or burning upon instillation","drugRate":"","severity":"common","organSystem":""},{"effect":"Conjunctival injection","drugRate":"","severity":"infrequent","organSystem":""},{"effect":"Watery eyes","drugRate":"","severity":"infrequent","organSystem":""},{"effect":"Itchy eyes","drugRate":"","severity":"infrequent","organSystem":""},{"effect":"Dryness around the eye","drugRate":"","severity":"infrequent","organSystem":""},{"effect":"Puffy eyes","drugRate":"","severity":"infrequent","organSystem":""},{"effect":"Eye irritation","drugRate":"","severity":"infrequent","organSystem":""},{"effect":"Styes","drugRate":"","severity":"infrequent","organSystem":""}],"contraindications":["Hypersensitivity to cromolyn sodium"],"specialPopulations":{"Pregnancy":"No adequate and well-controlled studies in pregnant women. Use only if clearly needed.","Geriatric use":"No specific guidance available.","Paediatric use":"Not recommended for pediatric patients under 2 years.","Renal impairment":"No specific guidance available.","Hepatic impairment":"No specific guidance available."},"seriousAdverseEvents":[{"effect":"Dyspnea","drugRate":"","severity":"serious"},{"effect":"Edema","drugRate":"","severity":"serious"},{"effect":"Rash","drugRate":"","severity":"serious"}]},"trials":[],"_chembl":null,"aliases":["sodium cromoglicate","cromoglicate sodium"],"patents":[],"pricing":[{"market":"United States","source":"CMS National Average Drug Acquisition Cost (NADAC)","asOfDate":"2024-01-03","unitCost":"$0.2598/ML","priceType":"NADAC","sourceUrl":"https://data.medicaid.gov/dataset/4j6z-xnwq","annualCost":"$94","description":"CROMOLYN 100 MG/5 ML ORAL CONC","retrievedDate":"2026-04-07"}],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=CROMOLYN SODIUM","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T00:33:10.915244+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T00:33:15.900649+00:00"},"regulatory.us":{"url":"","method":"api_direct","source":"FDA Drugs@FDA","rawText":"","confidence":1,"sourceType":"fda_drugsfda","retrievedAt":"2026-04-20T00:33:10.022370+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=CROMOLYN SODIUM","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T00:33:16.219084+00:00"},"safety.safetySignals":{"url":"https://api.fda.gov/drug/event.json","method":"api_direct","source":"FDA FAERS","rawText":"","confidence":1,"sourceType":"fda_faers","retrievedAt":"2026-04-20T00:33:18.354604+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL428880/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T00:33:17.534609+00:00"}},"allNames":"CROMOLYN SODIUM, cromoglicate sodium, cromolyn-sodium, sodium cromoglicate","offLabel":[],"timeline":[{"date":"","type":"positive","milestone":"FDA approval for mastocytosis","regulator":"FDA","description":"GASTROCROM received FDA approval for the management of patients with mastocytosis."}],"_dailymed":{"setId":"a742664b-265e-49f9-9744-d04e1fb620ae","title":"CROMOLYN SODIUM SOLUTION, CONCENTRATE [OMNIVIUM PHARMACEUTICALS LLC]"},"aiSummary":"Cromolyn Sodium is a mast cell stabilizer used primarily in the management of mastocytosis. It prevents the release of mediators like histamine from mast cells, reducing symptoms such as diarrhea, flushing, and headaches. Approved by the FDA, it is marketed as GASTROCROM and is administered orally. While it does not affect urinary histamine levels or peripheral eosinophilia, it provides clinically significant improvements in gastrointestinal and cutaneous symptoms. The drug is currently marketed and has a niche but important role in treating mastocytosis.","ecosystem":[],"mechanism":{"target":"Mast cells","novelty":"first-in-class","modality":"small molecule","drugClass":"Mast cell stabilizer","explanation":"","oneSentence":"","technicalDetail":"Cromolyn Sodium binds to mast cells, preventing degranulation and the subsequent release of histamine and other mediators. It is a small molecule with a unique mechanism of action, making it effective in managing mastocytosis symptoms."},"_scrapedAt":"2026-03-27T23:47:03.737Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"commercial":{"notes":"","yoyGrowth":"","launchDate":"","marketShare":"","revenueYear":"","annualCostUS":"","currentRevenue":"","percentOfCompany":"","patientPopulation":"","peakSalesEstimate":"","genericCompetition":"no"},"references":[],"_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:33:19.259286+00:00","fieldsConflicting":2,"overallConfidence":0.8},"biosimilars":[],"competitors":[],"dataSources":[{"url":"https://data.medicaid.gov/dataset/4j6z-xnwq","name":"CMS National Average Drug Acquisition Cost (NADAC)","fields":["pricing"],"retrievedDate":"2026-04-07"}],"indications":{"approved":[{"line":"any","name":"Mastocytosis","notes":"","regulator":"FDA","approvalDate":""}],"offLabel":[],"pipeline":[{"name":"Amyotrophic Lateral Sclerosis (ALS)","notes":"","phase":"Phase 2","status":"recruiting"},{"name":"Triple-negative Breast Cancer","notes":"","phase":"Phase 2","status":"not_yet_recruiting"},{"name":"Psoriasis","notes":"","phase":"Phase 2","status":"completed"},{"name":"Burn Scar Itch","notes":"","phase":"Phase 3","status":"recruiting"},{"name":"Eosinophilic Esophagitis","notes":"","phase":"Phase 4","status":"completed"}]},"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT03794076","phase":"PHASE1, PHASE2","title":"Cromoglicate Adjunctive Therapy for Outpatients With Schizophrenia","status":"RECRUITING","sponsor":"Vishwajit Nimgaonkar, MD PhD","startDate":"2019-04-01","conditions":"Schizophrenia, Schizo Affective Disorder","enrollment":160},{"nctId":"NCT07419880","phase":"PHASE2","title":"Re-challenge Immunotherapy With Cromolyn, TQB2102, and Panpulimab in Immune-Refractory Triple Negative Breast Cancer","status":"NOT_YET_RECRUITING","sponsor":"Fudan University","startDate":"2026-01-30","conditions":"Triple -Negative Breast Cancer","enrollment":46},{"nctId":"NCT07142291","phase":"PHASE2","title":"PHENOGENE-1A (Cromolyn) Treatment in Patients With Mild to Moderate ALS","status":"RECRUITING","sponsor":"PhenoNet, Inc.","startDate":"2025-11-25","conditions":"Amyotrophic Lateral Sclerosis (ALS)","enrollment":105},{"nctId":"NCT02131038","phase":"","title":"Application of Ectoine Nasal Spray in Comparison With Cromolyn Sodium Containing Nasal Spray in Patients With Allergic Rhinitis","status":"COMPLETED","sponsor":"Bitop AG","startDate":"2009-05","conditions":"Allergic Rhinitis","enrollment":50},{"nctId":"NCT05076682","phase":"PHASE2","title":"Reverse Triple Negative Immune Resistant Breast Cancer","status":"RECRUITING","sponsor":"Fudan University","startDate":"2022-06-30","conditions":"Triple-negative Breast Cancer","enrollment":80},{"nctId":"NCT06801626","phase":"PHASE3","title":"Novel Strategies for Reducing Burn Scar Itch","status":"RECRUITING","sponsor":"The University of Texas Medical Branch, Galveston","startDate":"2025-03-01","conditions":"Burn Scar, Itch Scarring, Wound","enrollment":44},{"nctId":"NCT01722812","phase":"PHASE2","title":"Cromoglicate in Psoriasis","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2012-11","conditions":"Psoriasis","enrollment":30},{"nctId":"NCT01701843","phase":"PHASE2","title":"Cromoglicate in Mastocytosis","status":"TERMINATED","sponsor":"LEO Pharma","startDate":"2012-10","conditions":"Mastocytosis","enrollment":7},{"nctId":"NCT03167216","phase":"EARLY_PHASE1","title":"Mast Cells in Male Pelvic Pain and and Lower Urinary Tract Dysfunction","status":"COMPLETED","sponsor":"Northwestern University","startDate":"2017-08-01","conditions":"Chronic Prostatitis With Chronic Pelvic Pain Syndrome","enrollment":20},{"nctId":"NCT05077917","phase":"PHASE3","title":"Cromolyn Sodium for Treatment of COVID-19 Pneumonia","status":"TERMINATED","sponsor":"Texas Tech University Health Sciences Center, El Paso","startDate":"2021-11-15","conditions":"COVID-19 Pneumonia, COVID-19 Respiratory Infection, Pneumonia, Viral","enrollment":22},{"nctId":"NCT06535087","phase":"","title":"The Impact of Airway Allergic Diseases on Children's and Parents' Quality of Life","status":"RECRUITING","sponsor":"Wenjing Zhou","startDate":"2024-07-20","conditions":"Pediatric Asthma, Rhinitis, Allergic, Quality of Life","enrollment":600},{"nctId":"NCT02664051","phase":"PHASE4","title":"Mast Cells in Acid-induced Intestinal Permeability","status":"TERMINATED","sponsor":"Universitaire Ziekenhuizen KU Leuven","startDate":"2013-08","conditions":"Dyspepsia","enrollment":20},{"nctId":"NCT04846348","phase":"PHASE2","title":"Topical Composition Therapy for the Treatment of Cutaneous Mastocytosis","status":"TERMINATED","sponsor":"Joseph Butterfield","startDate":"2021-07-26","conditions":"Cutaneous Mastocytoses","enrollment":1},{"nctId":"NCT02371941","phase":"PHASE4","title":"Oral Cromolyn Sodium for the Treatment of Eosinophilic Esophagitis","status":"COMPLETED","sponsor":"University of Tennessee","startDate":"2014-12","conditions":"Eosinophilic Esophagitis","enrollment":16},{"nctId":"NCT04408664","phase":"PHASE3","title":"Influence of Cromones on Eucapnic Hyperventilation (EVH)-Test in Young (Elite) Athletes Who Tested Positive for EIB.","status":"TERMINATED","sponsor":"Universitaire Ziekenhuizen KU Leuven","startDate":"2021-04-06","conditions":"Exercise-Induced Bronchoconstriction","enrollment":8},{"nctId":"NCT04333108","phase":"PHASE3","title":"Masitinib in Severe Indolent or Smoldering Systemic Mastocytosis Unresponsive to Optimal Symptomatic Treatment","status":"UNKNOWN","sponsor":"AB Science","startDate":"2020-07-01","conditions":"Indolent Systemic Mastocytosis","enrollment":140},{"nctId":"NCT05449444","phase":"PHASE2","title":"Masitinib for the Treatment of Severe Mast Cell Activation Syndrome","status":"UNKNOWN","sponsor":"AB Science","startDate":"2022-07-01","conditions":"Mast Cell Activation Syndrome","enrollment":72},{"nctId":"NCT04570644","phase":"PHASE1","title":"Randomized I/II Phase Study of ALZT-OP1 Combination Therapy in Alzheimer's Disease and Normal Healthy Volunteers","status":"COMPLETED","sponsor":"AZTherapies, Inc.","startDate":"2020-08-28","conditions":"Healthy Volunteers, Alzheimer Disease","enrollment":56},{"nctId":"NCT03202147","phase":"PHASE2","title":"Safety and Efficacy of ALZT-OP1a as Adjuvant Treatment in Subjects With Post-Ischemic Stroke Cognitive Impairment (PSCI)","status":"WITHDRAWN","sponsor":"AZTherapies, Inc.","startDate":"2023-12","conditions":"Ischemic Stroke, Post-stroke Cognitive Impairment","enrollment":""},{"nctId":"NCT00943397","phase":"PHASE3","title":"Extended Safety Study of Montelukast in Infants and Young Children With Chronic Asthma (0476-232)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2001-04","conditions":"Asthma","enrollment":190},{"nctId":"NCT02547818","phase":"PHASE3","title":"Safety and Efficacy Study of ALZT-OP1 in Subjects With Evidence of Early Alzheimer's Disease","status":"COMPLETED","sponsor":"AZTherapies, Inc.","startDate":"2015-09-15","conditions":"Alzheimer's Disease","enrollment":620},{"nctId":"NCT04428775","phase":"PHASE2","title":"A Safety and Biomarker Study of ALZT-OP1a in Subjects With Mild-Moderate ALS Disease","status":"TERMINATED","sponsor":"AZTherapies, Inc.","startDate":"2020-09-08","conditions":"Amyotrophic Lateral Sclerosis","enrollment":12},{"nctId":"NCT00814073","phase":"PHASE3","title":"Masitinib in Severe Indolent or Smoldering Systemic Mastocytosis","status":"COMPLETED","sponsor":"AB Science","startDate":"2008-12","conditions":"Indolent Systemic Mastocytosis","enrollment":135},{"nctId":"NCT01933464","phase":"PHASE1, PHASE2","title":"An Analysis of the Effect of Topical Cromolyn Sodium on Rosacea-associated Erythema","status":"COMPLETED","sponsor":"University of California, San Diego","startDate":"2013-08","conditions":"Papulopustular Rosacea","enrollment":10},{"nctId":"NCT01841307","phase":"PHASE1","title":"Cromolyn Detection of Silent Aspiration","status":"TERMINATED","sponsor":"University of California, San Francisco","startDate":"2015-07","conditions":"Gastroesophageal Reflux, Respiratory Aspiration, Idiopathic Pulmonary Fibrosis","enrollment":16},{"nctId":"NCT02566252","phase":"PHASE1","title":"Effect of Pre-Treatment With Cromolyn or Albuterol on Response to PUL-042 Inhalation Solution (PUL-042)","status":"COMPLETED","sponsor":"Pulmotect, Inc.","startDate":"2015-07","conditions":"Healthy","enrollment":16},{"nctId":"NCT01346852","phase":"","title":"Predictive Ability of Therapeutic Risk Factors in Pediatric and Adult Asthma Patients","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2009-07","conditions":"Asthma","enrollment":101437},{"nctId":"NCT02478957","phase":"PHASE2","title":"Treatment of Indolent Systemic Mastocytosis With PA101","status":"COMPLETED","sponsor":"Patara Pharma","startDate":"2015-06","conditions":"Mastocytosis, Systemic Mastocytosis, Indolent Systemic Mastocytosis","enrollment":41},{"nctId":"NCT02482324","phase":"PHASE1","title":"Phase 1 Study of ALZT-OP1 Combination Therapy in Normal Healthy Volunteers","status":"COMPLETED","sponsor":"AZTherapies, Inc.","startDate":"2015-06","conditions":"Healthy Volunteers","enrollment":26},{"nctId":"NCT01175525","phase":"PHASE3","title":"Treatment of Acute Stroke With Cromolyn(Single Dose)","status":"UNKNOWN","sponsor":"Wolfson Medical Center","startDate":"","conditions":"Acute Stroke","enrollment":""},{"nctId":"NCT00745199","phase":"PHASE2","title":"Evaluating the Effect of Cromolyn Sodium in Uremic Pruritus","status":"COMPLETED","sponsor":"Shiraz University of Medical Sciences","startDate":"2008-05","conditions":"End Stage Renal Disease, Pruritus","enrollment":62}],"_emaApprovals":[],"_faersSignals":[{"count":1006,"reaction":"TREATMENT FAILURE"},{"count":308,"reaction":"DRUG INEFFECTIVE"},{"count":166,"reaction":"FATIGUE"},{"count":157,"reaction":"NAUSEA"},{"count":150,"reaction":"HEADACHE"},{"count":133,"reaction":"DIARRHOEA"},{"count":132,"reaction":"URTICARIA"},{"count":120,"reaction":"OFF LABEL USE"},{"count":109,"reaction":"MALAISE"},{"count":108,"reaction":"HYPERSENSITIVITY"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{"icon":"💊","route":"oral","frequency":"four times daily","formulation":"solution"},"crossReferences":{"chemblId":"CHEMBL428880"},"formularyStatus":[],"_approvalHistory":[{"date":"20130404","type":"ORIG","sponsor":"MICRO LABS LTD INDIA","applicationNumber":"ANDA202745"},{"date":"20231205","type":"SUPPL","sponsor":"MICRO LABS LTD INDIA","applicationNumber":"ANDA202745"},{"date":"20231114","type":"SUPPL","sponsor":"MICRO LABS LTD INDIA","applicationNumber":"ANDA202745"},{"date":"20171016","type":"ORIG","sponsor":"AILEX PHARMS LLC","applicationNumber":"ANDA209264"},{"date":"20251002","type":"SUPPL","sponsor":"TEVA PHARMS","applicationNumber":"ANDA075271"},{"date":"20000118","type":"ORIG","sponsor":"TEVA PHARMS","applicationNumber":"ANDA075271"},{"date":"20010815","type":"SUPPL","sponsor":"TEVA PHARMS","applicationNumber":"ANDA075271"},{"date":"20080903","type":"SUPPL","sponsor":"TEVA PHARMS","applicationNumber":"ANDA075271"},{"date":"20010815","type":"SUPPL","sponsor":"TEVA PHARMS","applicationNumber":"ANDA075271"},{"date":"20021223","type":"SUPPL","sponsor":"SANDOZ","applicationNumber":"ANDA075282"},{"date":"20020328","type":"SUPPL","sponsor":"SANDOZ","applicationNumber":"ANDA075282"},{"date":"19991007","type":"SUPPL","sponsor":"SANDOZ","applicationNumber":"ANDA075282"},{"date":"19990616","type":"ORIG","sponsor":"SANDOZ","applicationNumber":"ANDA075282"},{"date":"20021001","type":"SUPPL","sponsor":"SANDOZ","applicationNumber":"ANDA075282"},{"date":"20000407","type":"SUPPL","sponsor":"SANDOZ","applicationNumber":"ANDA075282"},{"date":"20030213","type":"SUPPL","sponsor":"VIATRIS SPECIALTY","applicationNumber":"NDA020479"},{"date":"19991216","type":"SUPPL","sponsor":"VIATRIS SPECIALTY","applicationNumber":"NDA020479"},{"date":"19990310","type":"SUPPL","sponsor":"VIATRIS SPECIALTY","applicationNumber":"NDA020479"},{"date":"19960229","type":"ORIG","sponsor":"VIATRIS SPECIALTY","applicationNumber":"NDA020479"},{"date":"20000208","type":"SUPPL","sponsor":"VIATRIS SPECIALTY","applicationNumber":"NDA020479"}],"developmentCodes":[],"ownershipHistory":[],"publicationCount":774,"therapeuticAreas":["Oncology"],"trialPhaseCounts":{"":3,"PHASE1":4,"PHASE2":11,"PHASE3":8,"PHASE4":2,"EARLY_PHASE1":1,"PHASE1, PHASE2":2},"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"marketed","status":"approved","brandName":"CROMOLYN SODIUM","genericName":"CROMOLYN SODIUM","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"1982","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2000-02-08T00:00:00.000Z","mah":"VIATRIS SPECIALTY","brand_name_local":null,"application_number":"NDA020479"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2001-07-03T00:00:00.000Z","mah":"BAUSCH AND LOMB","brand_name_local":null,"application_number":"ANDA075702"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2017-10-16T00:00:00.000Z","mah":"AILEX PHARMS LLC","brand_name_local":null,"application_number":"ANDA209264"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2017-10-16T00:00:00.000Z","mah":"AILEX PHARMS LLC","brand_name_local":null,"application_number":"ANDA209453"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2023-11-14T00:00:00.000Z","mah":"MICRO LABS LTD INDIA","brand_name_local":null,"application_number":"ANDA202745"},{"country_code":"TR","regulator":"TITCK","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"IN","regulator":"CDSCO","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"TH","regulator":"FDA-TH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"MY","regulator":"NPRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"PH","regulator":"FDA-PH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"CO","regulator":"INVIMA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"ZA","regulator":"SAHPRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"TW","regulator":"TFDA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"HK","regulator":"DH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"IL","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"IL","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"IL","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"IL","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"IL","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"SG","regulator":"HSA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"SG","regulator":"HSA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"SG","regulator":"HSA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"SG","regulator":"HSA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"SG","regulator":"HSA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AE","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AE","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AE","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AE","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AE","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"KR","regulator":"MFDS","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"KR","regulator":"MFDS","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"KR","regulator":"MFDS","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"KR","regulator":"MFDS","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"KR","regulator":"MFDS","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AU","regulator":"TGA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AU","regulator":"TGA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AU","regulator":"TGA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AU","regulator":"TGA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AU","regulator":"TGA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"GB","regulator":"MHRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"GB","regulator":"MHRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"GB","regulator":"MHRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"GB","regulator":"MHRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"GB","regulator":"MHRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"BR","regulator":"ANVISA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"MX","regulator":"COFEPRIS","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AR","regulator":"ANMAT","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":1,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:33:19.259286+00:00","fieldsConflicting":2,"overallConfidence":0.8},"verificationStatus":"verified","dataCompleteness":{"mechanism":false,"indications":true,"safety":true,"trials":true,"score":3}}